The gut microbiomes of patients with antiphospholipid syndrome show higher levels of phospholipid-producing bacteria, and this findings point to microbes being a trigger for this life-threatening disease, according to new ...
Nov 13, 2016
0
7
Distinct gene expression signatures in rheumatoid arthritis patients could help rheumatologists predict how these individuals will respond to tumor necrosis factor inhibitors, and may one day enable a more personalized approach ...
Nov 13, 2016
0
6
People with rheumatoid arthritis have an increased risk of heart failure even when controlling for coronary artery disease. Chronic myocarditis, or heart inflammation, is one suspected risk factor for cardiovascular disease ...
Nov 13, 2016
0
36
Rheumatoid arthritis patients who keep using their disease-modifying antirheumatic drugs prior to surgery do not face an increased risk of infection after their procedures, according to new research findings presented this ...
Nov 13, 2016
0
0
Outcomes such as pain, function, range of motion, and strength after total hip arthroplasty, or joint replacement surgery, are different for men and women, which could lead to the development of sex-specific rehabilitation ...
Nov 13, 2016
0
0
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, describes a link between positive antiphospholipid antibodies and an increased risk of future cardiovascular disease in patients ...
Nov 7, 2023
0
3
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, found that JAK inhibitors (JAKi) and tocilizumab elicited better response rates in VEXAS syndrome compared to other targeted ...
Nov 7, 2023
0
1
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, shows that ultrasound-detected salivary gland abnormalities in primary Sjögren's become more severe over time and that the ...
Nov 7, 2023
0
20
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that 50% of people with low-grade proteinuria, which is protein in your urine, progress to clinical proteinuria ...
Nov 8, 2022
0
0
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that the B-cell inhibitor belimumab significantly improved cutaneous lupus erythematosus (CLE) whether ...
Nov 8, 2022
0
0
